Consensus for HER2 alterations testing in non-small-cell lung cancerShengxiang Ren, Fred R. Hirsch, Jianchun Duan et al.|ESMO Open|2022Cited by 110
Does major pathological response after neoadjuvant Immunotherapy in resectable nonsmall-cell lung cancers predict prognosis? A systematic review and meta-analysisYujia Chen, Jun Wang, Jianjun Qin et al.|International Journal of Surgery|2023Cited by 39
Neoadjuvant immunotherapy for advanced, resectable non–small cell lung cancer: A systematic review and meta‐analysisYajing Wu, Joe Y. Chang, Vivek Verma et al.|Cancer|2023Cited by 36
Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemnessMaoyuan Zhao, Zhouguang Hui|Thoracic Cancer|2020Cited by 16